GST rates reduced from 12 percent to 5 per cent on certain cancer drugs

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2024-09-10 09:06 GMT | Update On 2024-09-10 09:07 GMT

New Delhi: In an effort to reduce the overall cost for the treatment of cancer, the GST Council decided to reduce the GST rate on certain cancer drugs from 12 per cent to 5 per cent in a meeting held on Monday. These drugs are Trastuzumab Deruxtecan, Osimertinib, and Durvalumab.

In another decision, GST rate has been reduced prospectively from 18 per cent to 12 per cent for namkeens and savoury items.

Universities and research centers that have been established by a law of the Central Government; established by a law of the State Governments; and institutions that have obtained income tax exemption can receive research funds both government and from the private.

Such research-related funds would not attract taxes as they have been exempted from paying the GST.

According to a ANI report, a Group of Ministers has been tasked to look into GST rates related to medical insurance and come up with a report by October so that the GST Council can take up the matter in the November meeting.

"There were a lot of discussions about do we reduce the rate, or exempt it, for who should we exempt and who should not, what happens to group insurance, are we going to carve out only for senior citizens, will this not complicate the implementation," Finance Minister Nirmala Sitharaman told reporters after hours-long GST Council meeting held on Monday.

A lot of issues were brought up for further discussion in the GST Council, Sitharaman said, adding that's why they felt it should go through a rigorous look into by the GoM.

It will be the rate rationalization GoM headed by the Deputy Chief Minister of Bihar but with newer members added for this limited purpose.

"We have told them that they will look into this matter and come up with a report by the end of October 2024. The #GST council which will meet in November will finalize based on this report which will come from the GoM," she added.

Both life insurance and medical insurance premiums attract a GST rate of 18 per cent.

Recently, many leaders from opposition-ruled states have requested Finance Minister Sitharaman to reduce GST on medical insurance and premiums. West Bengal Chief Minister Mamata Banerjee has requested the central government to withdraw the Goods and Services Tax (GST) on life insurance and health insurance premiums.

GST Council also recommended the formation of a GoM to study the future of compensation cess.

The council also notified that GST at 5 per cent will be imposed on the transport of passengers by helicopters on seat share basis as against 18 per cent earlier. The charter helicopter will continue to attract 18 per cent GST.

GST rate on car seats to be increased from 18 per cent to 28 per cent. This uniform rate of 28 per cent will be applicable prospectively for car seats of motor cars in order to bring parity with seats of motorcycles which already attract a GST rate of 28 per cent.

Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

GST rates reduced from 12 percent to 5 per cent on certain cancer drugs

Similar News

Aurobindo Pharma Acquires Lannett for Rs 2,185 Cr to Boost U.S. Presence, ADHD Line

Novo Nordisk Appoints Mike Doustdar as New CEO Amid Executive Reshuffle

CDSCO Panel Withholds Nod for Syngene's Pegfilgrastim Trial, Seeks Additional Data

Zydus Told To Conduct Phase III Trial in India for Lurbinectedin Injection, BE Study Waived

AbbVie Eyes USD 1 Billion Buyout of Mental Health Drugmaker Gilgamesh

GSK Raises Outlook After Q2 Beat, Eyes USD 53.44B Sales by 2031

Top USFDA vaccine official Vinay Prasad exits agency

Akums Drugs & Pharma appoints Tarun Kapoor as CIO